GNRH1 and endometriosis: The similar efficacy of GnRH agonists with and without add-back therapy [78,79] suggests that for superficial endometriosis lesions, the pain reduction results mainly from reducing the high estrogen concentrations in peritoneal fluid, and that the threshold of estrogen concentrations inducing pain is higher than physiological concentrations.